Researchers at UCLA have successfully manipulated nanomaterials to create a new drug-delivery system that promises to solve the challenge of the poor water solubility of today?s most promising anticancer drugs and thereby increase their effectiveness.
Mutations in the cell adhesion molecule known as integrin alpha 7 (integrin ?7) lead to unchecked tumor cell proliferation and a significantly higher incidence in cancer spread, or metastasis, in several cancer cell lines, report researchers at the University of Pittsburgh School of Medicine in a study being published today in the Journal of the National Cancer Institute.
Targeting the function of a protein known as beta1-integrin might represent a novelapproach to cancer treatment, according to a paper published online in The EMBO Journalthis week.
In a special publication sent to thousands of oncologists nationwide this month, University of Rochester Medical Center scientists offer an in-depth examination of cancer-related fatigue, with hope that a better understanding of the topic will prompt new research and treatment.
Talcum powder has been used for generations to soothe babies? diaper rash and freshen women?s faces. But University of Florida researchers report the household product has an additional healing power: The ability to stunt cancer growth by cutting the flow of blood to metastatic lung tumors.
Two research teams have developed models for classifying the clinical outcomes of patients with nonsmall cell lung cancer using mass spectrometry techniques. The studies are published in the June 6 Journal of the National Cancer Institute.
A multi-center team, led by Vanderbilt-Ingram Cancer Center investigators, has discovered a ?signature? of proteins in the blood that predicts which non-small-cell lung cancer patients will live longer when they are treated with certain targeted cancer therapies.
GlaxoSmithKline (GSK) today announced final results of a Phase II proof-of-concept clinical trial of its investigational MAGE-A3 Antigen-Specific Cancer Immunotherapeutic (ASCI) in MAGE-A3 positive patients with stage IB or II Non-Small Cell Lung Cancer (NSCLC).
CSIRO scientists have joined the battle to save Australia?s iconic Tasmanian devils from the deadly cancer currently devastating devil populations.
Women on tamoxifen therapy who reported having hot flashes were less likely to develop recurrent breast cancer than those who did not report hot flashes, according to a study from the Moores Cancer Center at the University of California, San Diego (UCSD).